Results 321 to 330 of about 145,743 (338)

Antibody-drug conjugates

Sharad Agarwal, Ema Kikovska-Stojanovska
openaire   +2 more sources

Antibody-drug conjugates

2012
openaire   +1 more source

Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy

Nature Nanotechnology, 2019
Jinqiang Wang, Zhuxian Zhou, Qingsong Yu
exaly  

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

Cancer Cell, 2016
Nazzareno Dimasi, Hui Feng, Dorin Toader
exaly  

Advancing Antibody Drug Conjugation

Hematology/Oncology Clinics of North America, 2014
Nicole M. Okeley, Stephen C. Alley, Peter D. Senter   +2 more
openaire   +1 more source

Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-ResistantStreptococcus pneumoniae

New England Journal of Medicine, 2006
William Schaffner, Allen S Craig, Lee H Harrison   +2 more
exaly  

Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors

Nature Medicine, 2018
Julia Boshuizen, Oscar Krijgsman, Maarten A Ligtenberg   +2 more
exaly  

Meningococcal group A, C, Y and W-135 conjugate vaccine

Nature Reviews Drug Discovery, 2010
exaly  

Food and Drug Administration, Partner in Drug Development

Ca-A Cancer Journal for Clinicians, 2006
exaly  

Antibody–drug conjugate shows efficacy in lymphoma

Nature Reviews Drug Discovery, 2011
exaly